Avive Connect AED - Revolutionizing Cardiac Arrest Outcomes

Sudden Cardiac Arrest (SCA) kills more than 350,000 people every single year in the U.S. alone. Despite being a major public health issue, survival rates have unfortunately remained dismal at around 10% for decades. The problem is not that AEDs don’t work, the problem is that AEDs aren’t getting to those in need quick or often enough–less than 5% of all out of hospital cardiac arrest emergencies have an AED arrive. And over the last two decades, AEDs devices have seen little to no meaningful advancements designed to improve those outcomes. The need for a fresh and innovative approach was critically apparent. The Avive Connect AED, from Avive Solutions, is transforming the industry by challenging complacency in an innovation-stagnant industry, revolutionizing the system of response and increasing survival rates.

From the moment someone experiences cardiac arrest, each passing minute reduces their chance of survival by 7%. AED's accessibility, design, and usability literally makes the difference
between life and death. The revolutionary Avive Connect AED packs first-of-its-kind capabilities with the most advanced features in the industry into a smaller, lighter, and more intuitive connected device. The technology is as engaging as it is effective, with features that bring a human touch to the industry in the hopes of saving more lives from cardiac arrest. The Avive Connect AED sets a new standard of expectations — direct yet approachable screen-based experience during use, seamless transfer of valuable incident data, and automated remote monitoring to ensure anyone is ready to save a life. Avive’s innovative approach to AEDs mirrors the paradigm shifts and benefits that connected devices bring to other industries such as smartphones, home security, personal fitness, automobiles, and more.

2023 was a pivotal year for Avive Solutions. After securing the FDA’s Class III Pre-Market Approval for the Avive Connect AED, the agency’s most stringent level of approval, the device was made commercially available in June. Avive Solutions is on track to deploy 5,000 units by the end of the year, making this lifesaving device more readily available to people in need across the country.